{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:04:59Z","timestamp":1784275499048,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1135802C"],"award-info":[{"award-number":["TCVGH-1135802C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06231-z","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:50:00Z","timestamp":1782895800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predominant HLA class I associations with lupus nephritis susceptibility, histology class and reduced renal function in patients with systemic lupus erythematosus: a retrospective case-control study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7477-1049","authenticated-orcid":false,"given":"Wan-Ching","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3065","authenticated-orcid":false,"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-5304","authenticated-orcid":false,"given":"I-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-4350","authenticated-orcid":false,"given":"Chung-Mao","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9450-9144","authenticated-orcid":false,"given":"Yen-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9366-0879","authenticated-orcid":false,"given":"Jing-Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-5821","authenticated-orcid":false,"given":"Chih-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"7","key":"6231_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56(7):481\u2013490. https:\/\/doi.org\/10.1136\/jcp.56.7.481","journal-title":"J Clin Pathol"},{"issue":"8","key":"6231_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41581-023-00722-z","volume":"19","author":"C Mohan","year":"2023","unstructured":"Mohan C, Zhang T, Putterman C (2023) Pathogenic cellular and molecular mediators in lupus nephritis. Nat Rev Nephrol 19(8):491\u2013508. https:\/\/doi.org\/10.1038\/s41581-023-00722-z","journal-title":"Nat Rev Nephrol"},{"key":"6231_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneph.2015.33","volume":"11","author":"C Mohan","year":"2015","unstructured":"Mohan C, Putterman C (2015) Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 11:329\u2013341. https:\/\/doi.org\/10.1038\/nrneph.2015.33","journal-title":"Nat Rev Nephrol"},{"key":"6231_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarc\u00f3n GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55:252\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kev311","journal-title":"Rheumatology (Oxford)"},{"key":"6231_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D\u2019Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, No\u00ebl L-H, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023","journal-title":"Kidney Int"},{"key":"6231_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x","journal-title":"Kidney Int"},{"key":"6231_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2016.09.012","volume":"185","author":"T Iwamoto","year":"2017","unstructured":"Iwamoto T, Niewold TB (2017) Genetics of human lupus nephritis. Clin Immunol 185:32\u201339. https:\/\/doi.org\/10.1016\/j.clim.2016.09.012","journal-title":"Clin Immunol"},{"key":"6231_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41581-018-0057-8","volume":"14","author":"KJ Robson","year":"2018","unstructured":"Robson KJ, Ooi JD, Holdsworth SR, Rossjohn J, Kitching AR (2018) HLA and kidney disease: from associations to mechanisms. Nat Rev Nephrol 14:636\u2013655. https:\/\/doi.org\/10.1038\/s41581-018-0057-8","journal-title":"Nat Rev Nephrol"},{"key":"6231_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/1756-185x.12528","volume":"18","author":"Z Niu","year":"2015","unstructured":"Niu Z, Zhang P, Tong Y (2015) Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis. Int J Rheum Dis 18:17\u201328. https:\/\/doi.org\/10.1111\/1756-185x.12528","journal-title":"Int J Rheum Dis"},{"key":"6231_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/0961203320932219","volume":"29","author":"A Mahajan","year":"2020","unstructured":"Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, Bass D (2020) Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus 29:1011\u20131020. https:\/\/doi.org\/10.1177\/0961203320932219","journal-title":"Lupus"},{"key":"6231_CR11","first-page":"118","volume":"6","author":"G Atma","year":"2018","unstructured":"Atma G, Kusworini H, Handono K, Hani S, Mudjiwijono Handaru EKO, Gatot SL, Dian H, Etik M, Didi C (2018) The Importance of HLA-DRB1 Alleles in Patients with Lupus Nephritis. Turkish J Immunol 6:118\u2013122","journal-title":"Turkish J Immunol"},{"key":"6231_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2016.1208218","volume":"46","author":"O Bhallil","year":"2016","unstructured":"Bhallil O, Ibrahimi A, Ouadghiri s, Ouzeddoun N, Benseffaj N, Bayahia R, Essakalli M (2016) HLA Class II with Lupus Nephritis in Moroccan Patients. Immunol Investig 46:1\u20139. https:\/\/doi.org\/10.1080\/08820139.2016.1208218","journal-title":"Immunol Investig"},{"key":"6231_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/s0198-8859(03)00017-x","volume":"64","author":"M Marchini","year":"2003","unstructured":"Marchini M, Antonioli R, Lle\u00f2 A, Barili M, Caronni M, Origgi L, Vanoli M, Scorza R (2003) HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 64:462\u2013468. https:\/\/doi.org\/10.1016\/s0198-8859(03)00017-x","journal-title":"Hum Immunol"},{"key":"6231_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5527\/wjn.v5.i4.321","volume":"5","author":"L Visconti","year":"2016","unstructured":"Visconti L, Cernaro V, Ricciardi CA, Lacava V, Pellican\u00f2 V, Lacquaniti A, Buemi M, Santoro D (2016) Renal biopsy: Still a landmark for the nephrologist. World J Nephrol 5:321\u2013327. https:\/\/doi.org\/10.5527\/wjn.v5.i4.321","journal-title":"World J Nephrol"},{"key":"6231_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.coi.2020.05.008","volume":"64","author":"E Olson","year":"2020","unstructured":"Olson E, Geng J, Raghavan M (2020) Polymorphisms of HLA-B: influences on assembly and immunity. Curr Opin Immunol 64:137\u2013145. https:\/\/doi.org\/10.1016\/j.coi.2020.05.008","journal-title":"Curr Opin Immunol"},{"key":"6231_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1479-5876-1-8","volume":"1","author":"P Jin","year":"2003","unstructured":"Jin P, Wang E (2003) Polymorphism in clinical immunology \u2013 From HLA typing to immunogenetic profiling. J Translational Med 1:8. https:\/\/doi.org\/10.1186\/1479-5876-1-8","journal-title":"J Translational Med"},{"key":"6231_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41467-021-21975-x","volume":"12","author":"T Naito","year":"2021","unstructured":"Naito T, Suzuki K, Hirata J, Kamatani Y, Matsuda K, Toda T, Okada Y (2021) A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes. Nat Commun 12:1639. https:\/\/doi.org\/10.1038\/s41467-021-21975-x","journal-title":"Nat Commun"},{"key":"6231_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13040-021-00284-5","volume":"14","author":"C-W Chung","year":"2021","unstructured":"Chung C-W, Hsiao T-H, Huang C-J, Chen Y-J, Chen H-H, Lin C-H, Chou S-C, Chen T-S, Chung Y-F, Yang H-I, Chen Y-M (2021) Machine learning approaches for the genomic prediction of rheumatoid arthritis and systemic lupus erythematosus. BioData Min 14:52. https:\/\/doi.org\/10.1186\/s13040-021-00284-5","journal-title":"BioData Min"},{"key":"6231_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/gepi.22334","volume":"44","author":"N Vince","year":"2020","unstructured":"Vince N, Douillard V, Geffard E, Meyer D, Castelli EC, Mack SJ, Limou S, Gourraud PA (2020) SNP-HLA Reference Consortium (SHLARC): HLA and SNP data sharing for promoting MHC-centric analyses in genomics. Genet Epidemiol 44:733\u2013740. https:\/\/doi.org\/10.1002\/gepi.22334","journal-title":"Genet Epidemiol"},{"key":"6231_CR20","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"6231_CR21","doi-asserted-by":"crossref","unstructured":"Rovin BH, Ayoub I, Arora S (2021) Chap. 42 - The clinical evaluation of kidney disease in systemic lupus erythematosus. In: Tsokos GC (ed) Systemic Lupus Erythematosus (Second Edition), Academic Press, pp 379\u2013388","DOI":"10.1016\/B978-0-12-814551-7.00042-8"},{"key":"6231_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin","year":"1983","unstructured":"Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 75:382\u2013391. https:\/\/doi.org\/10.1016\/0002-9343(83)90338-8","journal-title":"Am J Med"},{"key":"6231_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461\u2013470. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00002","journal-title":"Ann Intern Med"},{"key":"6231_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640. https:\/\/doi.org\/10.1002\/art.1780350606","journal-title":"Arthritis Rheum"},{"key":"6231_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/tpj.2013.18","volume":"14","author":"X Zheng","year":"2014","unstructured":"Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, Weir BS (2014) HIBAG\u2013HLA genotype imputation with attribute bagging. Pharmacogenomics J 14:192\u2013200. https:\/\/doi.org\/10.1038\/tpj.2013.18","journal-title":"Pharmacogenomics J"},{"key":"6231_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41397-020-0156-3","volume":"20","author":"YH Huang","year":"2020","unstructured":"Huang YH, Khor SS, Zheng X, Chen HY, Chang YH, Chu HW, Wu PE, Lin YJ, Liao SF, Shen CY, Tokunaga K, Lee MH (2020) A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan Biobank. Pharmacogenomics J 20:695\u2013704. https:\/\/doi.org\/10.1038\/s41397-020-0156-3","journal-title":"Pharmacogenomics J"},{"key":"6231_CR27","doi-asserted-by":"publisher","first-page":"e1008092","DOI":"10.1371\/journal.pgen.1008092","volume":"15","author":"JE Molineros","year":"2019","unstructured":"Molineros JE, Looger LL, Kim K, Okada Y, Terao C, Sun C, Zhou XJ, Raj P, Kochi Y, Suzuki A, Akizuki S, Nakabo S, Bang SY, Lee HS, Kang YM, Suh CH, Chung WT, Park YB, Choe JY, Shim SC, Lee SS, Zuo X, Yamamoto K, Li QZ, Shen N, Porter LL, Harley JB, Chua KH, Zhang H, Wakeland EK, Tsao BP, Bae SC, Nath SK (2019) Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians. PLoS Genet 15:e1008092. https:\/\/doi.org\/10.1371\/journal.pgen.1008092","journal-title":"PLoS Genet"},{"key":"6231_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/rai2.12023","volume":"2","author":"X Wang","year":"2022","unstructured":"Wang X, Yang Y, Upreti B, Liu S, Cui R, Cheng Y, Tao L, Dong J, Li L, Xu J (2022) Association between HLA-B and HLA-DRB1 polymorphisms and systemic lupus erythematosus in Han population in China. Rheumatol Autoimmun 2:31\u201339. https:\/\/doi.org\/10.1002\/rai2.12023","journal-title":"Rheumatol Autoimmun"},{"key":"6231_CR29","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1681\/asn.2016121331","volume":"28","author":"R Xu","year":"2017","unstructured":"Xu R, Li Q, Liu R, Shen J, Li M, Zhao M, Wang M, Liao Q, Mao H, Li Z, Zhou N, Yin P, Li Y, Tang X, Wu T, Zhong Z, Wang Y, Ai Z, Wang O, Chen N, Yang X, Fang J, Fu P, Gu J, Ye K, Chen J, Dai L, Liu H, Liu Z, Liao Y, Wan J, Ding G, Zhao J, Zhang H, Fu S, Sun L, Zhang X, Yang H, Wang J, Wang J, Liu J, Li Y, Yu X (2017) Association Analysis of the MHC in Lupus Nephritis. J Am Soc Nephrol 28:3383\u20133394. https:\/\/doi.org\/10.1681\/asn.2016121331","journal-title":"J Am Soc Nephrol"},{"key":"6231_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/08820131003615480","volume":"39","author":"YM Mosaad","year":"2010","unstructured":"Mosaad YM, Hammad A, Youssef HM, Elhanbly S (2010) HLA-DRB1*15 confers susceptibility to juvenile SLE but is not associated with disease presentation: an Egyptian Study. Immunol Invest 39:235\u2013244. https:\/\/doi.org\/10.3109\/08820131003615480","journal-title":"Immunol Invest"},{"key":"6231_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/0961203308101955","volume":"18","author":"CF Pan","year":"2009","unstructured":"Pan CF, Wu CJ, Chen HH, Dang CW, Chang FM, Liu HF, Chu CC, Lin M, Lee YJ (2009) Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus 18:698\u2013704. https:\/\/doi.org\/10.1177\/0961203308101955","journal-title":"Lupus"},{"key":"6231_CR32","doi-asserted-by":"publisher","first-page":"661135","DOI":"10.3389\/fimmu.2021.661135","volume":"12","author":"P Satapornpong","year":"2021","unstructured":"Satapornpong P, Pratoomwun J, Rerknimitr P, Klaewsongkram J, Nakkam N, Rungrotmongkol T, Konyoung P, Saksit N, Mahakkanukrauh A, Amornpinyo W, Khunarkornsiri U, Tempark T, Wantavornprasert K, Jinda P, Koomdee N, Jantararoungtong T, Rerkpattanapipat T, Wang CW, Naisbitt D, Tassaneeyakul W, Ariyachaipanich M, Roonghiranwat T, Pirmohamed M, Chung WH, Sukasem C (2021) HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Front Immunol 12:661135. https:\/\/doi.org\/10.3389\/fimmu.2021.661135","journal-title":"Front Immunol"},{"key":"6231_CR33","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alo M (2018) HLA-B*58:01 is not the only risk factor associated with allopurinol-induced severe cutaneous adverse drug reactions. Annals of Translational Medicine:S7","DOI":"10.21037\/atm.2018.08.42"},{"key":"6231_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2011.03422.x","volume":"133","author":"ME Blais","year":"2011","unstructured":"Blais ME, Dong T, Rowland-Jones S (2011) HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 133:1\u20137. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03422.x","journal-title":"Immunology"},{"key":"6231_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.trim.2018.02.001","volume":"47","author":"MI de Holanda","year":"2018","unstructured":"de Holanda MI, Klumb E, Imada A, Lima LA, Alc\u00e2ntara I, Greg\u00f3rio F, Christiani LF, Martins CO, Timoner BE, Motta J, Pozzan R, P\u00f4rto LC (2018) The prevalence of HLA alleles in a lupus nephritis population. Transpl Immunol 47:37\u201343. https:\/\/doi.org\/10.1016\/j.trim.2018.02.001","journal-title":"Transpl Immunol"},{"key":"6231_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s42003-022-03717-x","volume":"5","author":"B Miglioranza Scavuzzi","year":"2022","unstructured":"Miglioranza Scavuzzi B, van Drongelen V, Kaur B, Fox JC, Liu J, Mesquita-Ferrari RA, Kahlenberg JM, Farkash EA, Benavides F, Miller FW, Sawalha AH, Holoshitz J (2022) The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope. Commun Biol 5:751. https:\/\/doi.org\/10.1038\/s42003-022-03717-x","journal-title":"Commun Biol"},{"key":"6231_CR37","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00296-023-05389-0","volume":"43","author":"E Calatayud","year":"2023","unstructured":"Calatayud E, Montomoli M, \u00c1vila A, Sancho Calabuig A, Alegre-Sancho JJ (2023) Experience with abatacept in refractory lupus nephritis. Rheumatol Int 43:2319\u20132326. https:\/\/doi.org\/10.1007\/s00296-023-05389-0","journal-title":"Rheumatol Int"},{"key":"6231_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00296-023-05409-z","volume":"44","author":"C Lao","year":"2024","unstructured":"Lao C, Van Dantzig P, White D, Rabindranath K, Foxall D, Lawrenson R (2024) Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematosus: a population-based study. Rheumatol Int 44:469\u2013475. https:\/\/doi.org\/10.1007\/s00296-023-05409-z","journal-title":"Rheumatol Int"},{"key":"6231_CR39","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00296-024-05579-4","volume":"44","author":"J Kosa\u0142ka-W\u0119giel","year":"2024","unstructured":"Kosa\u0142ka-W\u0119giel J, Dziedzic R, Siwiec-Ko\u017alik A, Spa\u0142kowska M, Milewski M, \u017buk-Kuwik J et al (2024) Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: a single-center retrospective study. Rheumatol Int 44:1283\u20131294. https:\/\/doi.org\/10.1007\/s00296-024-05579-4","journal-title":"Rheumatol Int"},{"key":"6231_CR40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/jcma.0000000000001009","volume":"86","author":"CY Yen","year":"2023","unstructured":"Yen CY, Wang PY, Chen KY, Tseng CC, Wu CC, Ou TT, Yen JH (2023) HLA-DR genotypes in patients with systemic lupus erythematosus in Taiwan. J Chin Med Assoc 86:1060\u20131065. https:\/\/doi.org\/10.1097\/jcma.0000000000001009","journal-title":"J Chin Med Assoc"},{"key":"6231_CR41","first-page":"831","volume":"2","author":"I El-Haj","year":"2014","unstructured":"El-Haj I, Ismail A, El-Halafawy K, Mortada W, Elsherbini S (2014) Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Egyptians. Int J Adv Res 2:831\u2013838","journal-title":"Int J Adv Res"},{"key":"6231_CR42","doi-asserted-by":"publisher","first-page":"e15319","DOI":"10.1111\/tan.15319","volume":"103","author":"JA Noble","year":"2024","unstructured":"Noble JA, Besan\u00e7on S, Sidib\u00e9 AT, Rozemuller EH, Rijkers M, Dadkhodaie F, de Bruin H, Kooij J, Martin HRN, Ogle GD, Mack SJ (2024) Complete HLA genotyping of type 1 diabetes patients and controls from Mali reveals both expected and novel disease associations. Hla 103:e15319. https:\/\/doi.org\/10.1111\/tan.15319","journal-title":"Hla"},{"key":"6231_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12864-023-09351-z","volume":"24","author":"A Claeys","year":"2023","unstructured":"Claeys A, Merseburger P, Staut J, Marchal K, Van den Eynden J (2023) Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data. BMC Genomics 24:247. https:\/\/doi.org\/10.1186\/s12864-023-09351-z","journal-title":"BMC Genomics"},{"key":"6231_CR44","doi-asserted-by":"publisher","first-page":"875283","DOI":"10.3389\/fimmu.2022.875283","volume":"13","author":"TN Que","year":"2022","unstructured":"Que TN, Khanh NB, Khanh BQ, Van Son C, Van Anh NT, Anh TTT, Tung PD, Thang ND (2022) Allele and Haplotype Frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 Cord Blood Units From a Kinh Vietnamese Population. Front Immunol 13:875283. https:\/\/doi.org\/10.3389\/fimmu.2022.875283","journal-title":"Front Immunol"},{"key":"6231_CR45","doi-asserted-by":"publisher","first-page":"16972","DOI":"10.1038\/srep16972","volume":"5","author":"TH Lam","year":"2015","unstructured":"Lam TH, Tay MZ, Wang B, Xiao Z, Ren EC (2015) Intrahaplotypic Variants Differentiate Complex Linkage Disequilibrium within Human MHC Haplotypes. Sci Rep 5:16972. https:\/\/doi.org\/10.1038\/srep16972","journal-title":"Sci Rep"},{"key":"6231_CR46","doi-asserted-by":"publisher","first-page":"774916","DOI":"10.3389\/fgene.2021.774916","volume":"12","author":"V Douillard","year":"2021","unstructured":"Douillard V, Castelli EC, Mack SJ, Hollenbach JA, Gourraud PA, Vince N, Limou S (2021) Approaching Genetics Through the MHC Lens: Tools and Methods for HLA Research. Front Genet 12:774916. https:\/\/doi.org\/10.3389\/fgene.2021.774916","journal-title":"Front Genet"},{"key":"6231_CR47","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1093\/rheumatology\/keac067","volume":"61","author":"PM Carlucci","year":"2022","unstructured":"Carlucci PM, Li J, Fava A, Deonaraine KK, Wofsy D, James JA, Putterman C, Diamond B, Davidson A, Fine DM, Monroy-Trujillo J, Atta MG, DeJager W, Guthridge JM, Haag K, Rao DA, Brenner MB, Lederer JA, Apruzzese W, Belmont HM, Izmirly PM, Zaminski D, Wu M, Connery S, Payan-Schober F, Furie R, Dall\u2019Era M, Cho K, Kamen D, Kalunian K, Anolik J, Barnas J, Ishimori M, Weisman MH, Buyon JP, Petri M (2022) High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. Rheumatology (Oxford) 61:4335\u20134343. https:\/\/doi.org\/10.1093\/rheumatology\/keac067","journal-title":"Rheumatology (Oxford)"},{"key":"6231_CR48","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.ekir.2020.09.007","volume":"5","author":"A Chedid","year":"2020","unstructured":"Chedid A, Rossi GM, Peyronel F, Menez S, Atta MG, Bagnasco SM, Arend LJ, Rosenberg AZ, Fine DM (2020) Low-Level Proteinuria in Systemic Lupus Erythematosus. Kidney Int Rep 5:2333\u20132340. https:\/\/doi.org\/10.1016\/j.ekir.2020.09.007","journal-title":"Kidney Int Rep"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06231-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06231-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06231-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:17:21Z","timestamp":1784272641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06231-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6231"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06231-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest in relation to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"182"}}